Drugs / VSTs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02510417 | Oct 2014 → Sep 2017 | viral infectious disease | Catherine Bollard | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VSTs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02510417 ↗ |
| Modality | Cell therapy | “multivirus-specific T cell lines” NCT02510417 ↗ |
| Route | Other | “as a single infusion” NCT02510417 ↗ |